EVH:NYE-Evolent Health Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 8.83

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.80M

Analyst Target

USD 11.67
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-17 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
DOCS Doximity Inc

N/A

USD 11.11B
WEAV Weave Communications Inc

N/A

USD 0.71B
AMWL American Well Corp

N/A

USD 0.11B
CTEV Claritev Corporation

N/A

N/A
PHR Phreesia Inc

N/A

N/A
TDOC Teladoc Inc

N/A

N/A
VEEV Veeva Systems Inc Class A

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A

ETFs Containing EVH

ACTV LeaderShares® Activist L.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.51% 25% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.51% 25% F 8% B-
Trailing 12 Months  
Capital Gain -61.73% 13% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.73% 13% F 2% F
Trailing 5 Years  
Capital Gain 10.79% 75% C 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.79% 75% C 25% F
Average Annual (5 Year Horizon)  
Capital Gain 18.76% 88% B+ 83% B
Dividend Return 18.76% 88% B+ 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 61.55% 50% F 12% F
Risk Adjusted Return 30.48% 88% B+ 48% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector